Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer-Reference-Cited by-同舟云学术

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer

Published:2013-07 Issue:7 Volume:24 Page:1762-1769
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

van Dijk T.H.,Tamas K.,Beukema J.C.,Beets G.L.,Gelderblom A.J.,de Jong K.P.,Nagtegaal I.D.,Rutten H.J.,van de Velde C.J.,Wiggers T.,Hospers G.A.,Havenga K.

Funder

European Society for Medical Oncology (ESMO) Translational Research Fellowship

Sanofi-aventis Netherlands BV

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/7/1762/13789585/mdt124.pdf

Reference46 articles.

1. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer;Ceelen;Cochrane Database Syst Rev,2009

2. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203;Gerard;J Clin Oncol,2006